Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martha Skup

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Rheumatology and Therapy|August 2, 2017
Comparative Effectiveness of Adalimumab versus Secukinumab for the Treatment of Psoriatic Arthritis: A Matching-Adjusted Indirect ComparisonVibeke Strand, Keith A Betts, Manish Mittal, et al.
Journal of Managed Care & Specialty Pharmacy|July 25, 2017
Impact of a Patient Support Program on Patient Adherence to Adalimumab and Direct Medical Costs in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing SpondylitisDavid T Rubin, Manish Mittal, Matthew Davis, et al.
Current Medical Research and Opinion|September 9, 2017
Psychometric evaluation of the Rheumatoid Arthritis Symptom Questionnaire (RASQ) in an observational studyBenjamin Banderas, Martha Skup, Alan L Shields, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 20, 2014
Increased risk of venous thromboembolic events with corticosteroid vs biologic therapy for inflammatory bowel diseasePeter D R Higgins, Martha Skup, Parvez M Mulani, et al.
Advances in Therapy|June 7, 2019
Economic Impact of Non-Medical Switching from Originator Biologics to Biosimilars: A Systematic Literature ReviewYifei Liu, Min Yang, Vishvas Garg, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|March 11, 2010
A genome-wide association study of amygdala activation in youths with and without bipolar disorderXinmin Liu, Nirmala Akula, Martha Skup, et al.
Advances in Therapy|March 17, 2015
Nomenclature and traceability debate for biosimilars: small-molecule surrogates lend support for distinguishable nonproprietary namesJingdong Chao, Martha Skup, Emily Alexander, et al.
Inflammatory Bowel Diseases|September 30, 2017
Indirect Costs and Family Burden of Pediatric Crohn's Disease in the United StatesStacy A Kahn, Chia-Wei Lin, Burak Ozbay, et al.
Inflammatory Bowel Diseases|February 26, 2016
Biological and Immunomodulator Use in Crohn's Disease in a Medicaid PopulationMark H Flasar, Jingdong Chao, A Burak Ozbay, et al.
Ophthalmology|December 30, 2015
Risk of Ocular Complications in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or PanuveitisAndrew D Dick, Namita Tundia, Rachael Sorg, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Rheumatology and Therapy|August 2, 2017
Comparative Effectiveness of Adalimumab versus Secukinumab for the Treatment of Psoriatic Arthritis: A Matching-Adjusted Indirect ComparisonVibeke Strand, Keith A Betts, Manish Mittal, et al.
Journal of Managed Care & Specialty Pharmacy|July 25, 2017
Impact of a Patient Support Program on Patient Adherence to Adalimumab and Direct Medical Costs in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing SpondylitisDavid T Rubin, Manish Mittal, Matthew Davis, et al.
Current Medical Research and Opinion|September 9, 2017
Psychometric evaluation of the Rheumatoid Arthritis Symptom Questionnaire (RASQ) in an observational studyBenjamin Banderas, Martha Skup, Alan L Shields, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 20, 2014
Increased risk of venous thromboembolic events with corticosteroid vs biologic therapy for inflammatory bowel diseasePeter D R Higgins, Martha Skup, Parvez M Mulani, et al.
Advances in Therapy|June 7, 2019
Economic Impact of Non-Medical Switching from Originator Biologics to Biosimilars: A Systematic Literature ReviewYifei Liu, Min Yang, Vishvas Garg, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|March 11, 2010
A genome-wide association study of amygdala activation in youths with and without bipolar disorderXinmin Liu, Nirmala Akula, Martha Skup, et al.
Advances in Therapy|March 17, 2015
Nomenclature and traceability debate for biosimilars: small-molecule surrogates lend support for distinguishable nonproprietary namesJingdong Chao, Martha Skup, Emily Alexander, et al.
Inflammatory Bowel Diseases|September 30, 2017
Indirect Costs and Family Burden of Pediatric Crohn's Disease in the United StatesStacy A Kahn, Chia-Wei Lin, Burak Ozbay, et al.
Inflammatory Bowel Diseases|February 26, 2016
Biological and Immunomodulator Use in Crohn's Disease in a Medicaid PopulationMark H Flasar, Jingdong Chao, A Burak Ozbay, et al.
Ophthalmology|December 30, 2015
Risk of Ocular Complications in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or PanuveitisAndrew D Dick, Namita Tundia, Rachael Sorg, et al.
Pageof 5